SCOLR PHARMA INC Earnings Conference Call (Q1 2008)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other May 2 Calls Today's Calls

Call Details SCOLR PHARMA INC Earnings Conference Call (Q1 2008) Fri, May 2, 2008, 11:30 am Eastern Listen to the archived event audio About SCOLR PHARMA INC (AMEX:DDD) SCOLR Pharma, Inc., a pharmaceutical company, develops and formulates over-the-counter products, prescription drugs, and dietary supplement products using its controlled delivery technology platform. The company’s technology is used to develop dietary supplement products, including combinations of glucosamine and chondroitin, niacin, calcium, and other dietary products. Its product include Ibuprofen, an analgesic used for the treatment of pain, fever, and inflammation; Pseudoephedrine, a decongestant that is used to relieve sinus pressure related to allergies and common cold; Raloxifene, an ingredient in Evista, which is used for osteoporosis; Ondansetron, a drug in Zofran that is used for anti-nausea and vomiting associated with chemotherapy and radiation treatments for cancer; Peramivir, a part of a class of antiviral agents that inhibit influenza neuraminidase, an enzyme essential for the influenza virus to spread and infect its hosts; Rivastigmine, an ingredient in Exelon used for the management of Alzheimer’s disease; Risperidone, an ingredient in Risperdal that is used for the management of schizophrenia and bipolar mania; and Fenofibrate, a drug in Tricor for hypercholesterolemia. The company has strategic alliance with Perrigo Company for the manufacture, marketing, distribution, and sale of certain dietary supplements in the United States; research collaboration with BioCryst Pharmaceuticals to develop an oral formulation of peramivir, an antiviral compound using its CDT platform; and a collaboration and license agreement with Dr. Reddy's Laboratories. SCOLR Pharma was founded in 1983. It was formerly known as Caddy Systems, Inc. and changed its name to Nutraceutix, Inc. in 1995. Further, the company changed its name to SCOLR, Inc. in 2002 and to SCOLR Pharma, Inc. in 2004. SCOLR Pharma, Inc. is headquartered in Bellevue, Washington. More Info: Quote | Chart | News | Profile | Reports | Research | Msgs | Insider | Financials